Medications
EU approves Novartis's advanced breast cancer drug
EU regulators have approved Novartis's new Piqray drug to treat advanced breast cancer, the Swiss pharma giant said Wednesday.
Jul 29, 2020
0
5
News tagged with novartis
Medical research
Novartis holds off on drug price hikes in US amid Trump pressure
Swiss pharmaceutical giant Novartis said Wednesday it would not hike drug prices in the United States this year, following a similar decision by rival Pfizer amid pressure from the White House.
Jul 18, 2018
0
0
Cardiology
Canakinumab reduces risk of cardiovascular events in populations with unmet clinical need
Two new analyses of data from more than 10,000 heart attack survivors worldwide were presented by investigators from Brigham and Women's Hospital at the 2018 American College of Cardiology meeting. Paul Ridker, MD, director ...
Mar 12, 2018
0
1
Diseases, Conditions, Syndromes
Secukinumab effective for moderate / severe scalp psoriasis
(HealthDay)—Secukinumab is safe and effective as a treatment for patients with extensive moderate-to-severe scalp psoriasis, according to a study published in the October issue of the Journal of the American Academy of ...
Sep 29, 2017
0
0
Oncology & Cancer
'Breakthrough' leukemia drug also portends 'quantum leap' in cost
When doctors talk about a new leukemia drug from Novartis, they ooze enthusiasm, using words like "breakthrough," "revolutionary" and "a watershed moment."
Aug 24, 2017
0
3
Cardiology
FDA approves new heart failure pill from Novartis
Government regulators have approved a new pill from Novartis to treat heart failure, a deadly chronic disease that affects millions of U.S. patients.
Jul 7, 2015
0
6
Medications
Britain to offer all infants meningitis B vaccine
Britain says it will become the first country to offer all babies a vaccine for potentially fatal meningitis B after it reached a price deal with GlaxoSmithKline PLC.
Mar 29, 2015
0
14
Medications
FDA approves first lower-cost biotech drug (Update)
Federal health officials have approved the first lower-cost copy of a biotech drug to reach the U.S. market, a long-awaited milestone that could generate billions in savings for insurers, doctors and patients.
Mar 6, 2015
0
9
Medications
Novartis Japan facing penalty over drug side effects
Japanese health authorities said Wednesday that they will soon make a decision on a possible penalty against the local unit of Swiss pharmaceutical giant Novartis for failing to report drug side effects.
Feb 4, 2015
0
4
Medications
FDA panel endorses first lower-cost biotech drug
Federal health experts have unanimously endorsed a Novartis drug which is expected to become the first lower-cost copy of a biotech drug to reach the U.S. market.
Jan 7, 2015
0
10
